E.U.: Refusal to License Database May Be Monopoly Abuse
The case concerns the right of U.S. health information provider NDCHealth to demand a licence to the marketing database of its larger U.S. competitor, IMS Health.
IMS Health markets a service called RPM 1860, which helps German pharmaceutical companies track the flow of drug...
To view the full article, register now.